Your browser doesn't support javascript.
loading
Ex vivo expansion of lung cancer-derived disseminated cancer cells from lymph nodes identifies cells associated with metastatic progression.
Treitschke, Steffi; Weidele, Kathrin; Varadarajan, Adithi Ravikumar; Feliciello, Giancarlo; Warfsmann, Jens; Vorbeck, Sybille; Polzer, Bernhard; Botteron, Catherine; Hoffmann, Martin; Dechand, Vadim; Mederer, Tobias; Weber, Florian; Werner-Klein, Melanie; Robold, Tobias; Hofmann, Hans-Stefan; Werno, Christian; Klein, Christoph A.
Afiliación
  • Treitschke S; Fraunhofer Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Regensburg, Germany.
  • Weidele K; Fraunhofer Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Regensburg, Germany.
  • Varadarajan AR; Fraunhofer Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Regensburg, Germany.
  • Feliciello G; Fraunhofer Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Regensburg, Germany.
  • Warfsmann J; Fraunhofer Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Regensburg, Germany.
  • Vorbeck S; Fraunhofer Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Regensburg, Germany.
  • Polzer B; Fraunhofer Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Regensburg, Germany.
  • Botteron C; Fraunhofer Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Regensburg, Germany.
  • Hoffmann M; Fraunhofer Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Regensburg, Germany.
  • Dechand V; Fraunhofer Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Regensburg, Germany.
  • Mederer T; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
  • Weber F; Fraunhofer Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Regensburg, Germany.
  • Werner-Klein M; Institute for Pathology, University of Regensburg, Regensburg, Germany.
  • Robold T; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
  • Hofmann HS; Department of Thoracic Surgery, University Hospital Regensburg, Regensburg, Germany.
  • Werno C; Department of Thoracic Surgery, University Hospital Regensburg, Regensburg, Germany.
  • Klein CA; Fraunhofer Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Regensburg, Germany.
Int J Cancer ; 153(10): 1854-1867, 2023 11 15.
Article en En | MEDLINE | ID: mdl-37555668
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Moléculas de Adhesión Celular / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Moléculas de Adhesión Celular / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos